Your browser doesn't support javascript.
loading
Research Priorities on the Role of α-Synuclein in Parkinson's Disease Pathogenesis.
Burré, Jacqueline; Edwards, Robert H; Halliday, Glenda; Lang, Anthony E; Lashuel, Hilal A; Melki, Ronald; Murayama, Shigeo; Outeiro, Tiago F; Papa, Stella M; Stefanis, Leonidas; Woerman, Amanda L; Surmeier, Dalton James; Kalia, Lorraine V; Takahashi, Ryosuke.
Afiliação
  • Burré J; Appel Institute for Alzheimer's Disease Research and Brain and Mind Research Institute, Weill Cornell Medicine, New York, New York, USA.
  • Edwards RH; Department of Physiology and Neurology, University of California, San Francisco School of Medicine, San Francisco, California, USA.
  • Halliday G; Brain and Mind Centre, School of Medical Sciences, The University of Sydney, Camperdown, New South Wales, Australia.
  • Lang AE; Edmond J. Safra Program in Parkinson's Disease, Krembil Research Institute, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada.
  • Lashuel HA; Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Melki R; Laboratory of Chemical Biology of Neurodegeneration, Brain Mind Institute, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
  • Murayama S; Institut Francois Jacob (MIRCen), CEA and Laboratory of Neurodegenerative Diseases, CNRS, Fontenay-Aux-Roses, France.
  • Outeiro TF; Department of Neuropathology, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo, Japan.
  • Papa SM; The Brain Bank for Neurodevelopmental, Neurological and Psychiatric Disorders, United Graduate School of Child Development, Osaka University, Osaka, Japan.
  • Stefanis L; Department of Experimental Neurodegeneration, University Medical Center, Göttingen, Germany.
  • Woerman AL; Faculty of Medical Sciences, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Surmeier DJ; Department of Neurology, School of Medicine, and Emory National Primate Research Center, Emory University, Atlanta, Georgia, USA.
  • Kalia LV; First Department of Neurology, Eginitio Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Takahashi R; Biomedical Research Foundation of the Academy of Athens, Athens, Greece.
Mov Disord ; 2024 Jun 30.
Article em En | MEDLINE | ID: mdl-38946200
ABSTRACT
Various forms of Parkinson's disease, including its common sporadic form, are characterized by prominent α-synuclein (αSyn) aggregation in affected brain regions. However, the role of αSyn in the pathogenesis and evolution of the disease remains unclear, despite vast research efforts of more than a quarter century. A better understanding of the role of αSyn, either primary or secondary, is critical for developing disease-modifying therapies. Previous attempts to hone this research have been challenged by experimental limitations, but recent technological advances may facilitate progress. The Scientific Issues Committee of the International Parkinson and Movement Disorder Society (MDS) charged a panel of experts in the field to discuss current scientific priorities and identify research strategies with potential for a breakthrough. © 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Mov Disord Assunto da revista: NEUROLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Mov Disord Assunto da revista: NEUROLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos